A Neurotrophic & Nootropic Formulation with BDNF and NGF mRNA Expression Enhancement Features for the Treatment of Neurological Damage & Development Disorders

A Neurotrophic and Nootropic Formulation consisting of a Pro-Somathropic Dioscin Analouge with increased systemic duration due to prolonged half-life, a Gymnemic Acid Analouge with BDNF NGF and neurotrophin B3 mRNA Expression Enhancing Properties. Formulation may serve as an adjuvant curative means for Neurological Development Defects along with Chronical Cerebrospinal Ailments like Dementia, Neuromascular Defects and other Neurodegenerative Disorders.